Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy

CONTEXT: Two tyrosine kinase inhibitors (TKIs), lenvatinib and vandetanib, are often used to treat advanced radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) and medullary thyroid cancer (MTC), respectively. Fatigue is a common adverse event during treatment with these and other TKIs...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Endocrinol Metab
Main Authors: Colombo, Carla, De Leo, Simone, Di Stefano, Marta, Vannucchi, Guia, Persani, Luca, Fugazzola, Laura
Format: Artigo
Sprog:Inglês
Udgivet: Endocrine Society 2018
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6402317/
https://ncbi.nlm.nih.gov/pubmed/30383218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01836
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker